SLC7A11 and pulmonary fibrosis: Furthermore, tuberostemonine enhances solute carrier family 7 member 11 (SLC7A11)/glutamate transporter expression, inhibits ferroptosis, and reduces inflammation and collagen deposition in the lung, thereby reducing pulmonary fibrosis [55].